Retatrutide improved sleep apnea in two phase 3 trials published in NEJM
By week 80, up to half of participants were down to mild apnea. Lead author Ron Grunstein credits weight loss, not a direct effect on breathing.
Recap by typeshit. Full story at Medical News Today.